ASCO 2026: AI Challenges a Breast Cancer Standard - Top_Thought_Leaders - MDSpire

ASCO 2026: AI Challenges a Breast Cancer Standard

New data suggest AI-based analysis of pathology slides may provide additional prognostic information, particularly for patients in the intermediate-risk category

  • By

  • Jessica Allerton

  • June 4, 2026

  • 3 min

Share

Top Thought Leaders in Oncology

Brief introduction explaining scope and methodology.

Original Source(s)

ASCO 2026: AI Challenges a Breast Cancer Standard

  • by Jessica Allerton

  • June 4, 2026

Related Content

HiGATE: hierarchical graph attention for multi-scale tissue encoder in computational pathology

Tumor antigen-associated autoantibodies: generation mechanisms, roles in tumorigenesis and progression, and clinical application prospects

Tertiary lymphoid structures in breast cancer: formation, immune functions and clinical implications